
|Articles|June 1, 2002
Tazarotene tackles nevi
New Orleans - Topical tazarotene gel 0.1 percent (Tazorac) can improve the appearance of epidermal nevi and may be worthwhile to consider as an effective and generally well-tolerated modality in children with lesions that are large and present in cosmetically important areas, or for patients who do not wish to have surgery,
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
4
Meta-analysis Confirms Benefits of Roflumilast 0.3% Cream for PsO
5


















